Lab Tested

Third-party tested for purity

Research Use Only

Not for human consumption

Discreet Shipping

Secure & discreet delivery

Quality Guaranteed

99%+ Purity Guaranteed

In Stock

Retatrutide

Original price was: $125.00.Current price is: $100.00.

SAVE 20% Limited Time Offer

Important Research Information

Retatrutide remains investigational and has not yet been approved by regulatory agencies. Phase 3 topline announcements are also not a substitute for complete peer-reviewed publications and regulatory review. Products sold online claiming to contain retatrutide should not be treated as equivalent to the investigational medicine used in controlled clinical trials.

Evidence note: Phase 2 human data are published; positive Phase 3 topline results were reported in 2026. Retatrutide remains investigational.

Buy 5, Get 1 Free

Investigational Triple-Receptor Agonist for Metabolic & Obesity Research

Retatrutide is an investigational peptide-based medication that activates three hormone receptors: GIP, GLP-1 and glucagon. This triple-receptor design separates it from single- and dual-receptor incretin therapies and has made it a major focus of obesity and metabolic research.

Why Researchers Are Interested

✓ Body-Weight Research Clinical trials have investigated substantial changes in body weight in adults with obesity or overweight.
✓ GLP-1 Activity Targets the GLP-1 receptor, which plays a role in appetite, glucose regulation and energy intake.
✓ GIP Activity Also activates the GIP receptor, adding a second incretin pathway to the research profile.
✓ Glucagon Activity Studies are examining glucagon-receptor activity and its potential contribution to energy expenditure and metabolic effects.
✓ Glycemic Measures Clinical studies have examined A1C, fasting glucose, insulin and related cardiometabolic markers.
✓ Cardiometabolic Research Large clinical programs are evaluating obesity and associated metabolic complications.

Why This Research Matters

Unlike many peptides discussed online, retatrutide has undergone evaluation in randomized human clinical trials. A published Phase 2 obesity trial found dose-dependent reductions in body weight over 48 weeks and also examined waist circumference, glucose regulation, insulin, lipids and blood pressure. Gastrointestinal adverse events were the most common, and the trial also reported dose-dependent increases in heart rate. In 2026, the developer reported positive topline results from multiple Phase 3 TRIUMPH studies, including studies in adults with obesity, type 2 diabetes and cardiovascular disease.

Research Areas at a Glance

  • Body-Weight Research
  • GLP-1 Activity
  • GIP Activity
  • Glucagon Activity
  • Glycemic Measures
  • Cardiometabolic Research

Research Use Only

Not for human consumption. For laboratory research purposes only.

Product Details

Peptide: 12 mg Retatrutide
Concentration: 12 mg per vial
Form: Lyophilized powder
Purity: 99%+ (HPLC Tested)
Storage: Store refrigerated (2°C - 8°C)
Reconstitution: Add bacteriostatic water (not included)
Usage: Research use only
Country of Origin: Canada

Certificate of Analysis

We provide a Certificate of Analysis for every batch.

  • Click the button to download the COA for this product.

Third-Party Tested

Purity and identity verified by independent laboratory testing.

Lab Tested

Every batch is third-party tested for purity and identity.

Research Use Only

Products are for laboratory research purposes only.

Discreet Shipping

All orders are shipped discreetly and securely.

Quality Guaranteed

99%+ purity guaranteed on all peptide products.

BPC-157

🇨🇦 Made in Canada · 🧪 Lab tested

WELCOME OFFER

Get 10% off your first order

Join the Peptides Plus newsletter for new releases and restock alerts. Your one-time code arrives by email straight away.

One use, valid for 30 days. No spam – unsubscribe anytime. See our Privacy Policy.